3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
71
Leukemia, Lymphocytic, Chronic, B-Cell
62
Hodgkin Disease
59
Precursor Cell Lymphoblastic Leukemia-Lymphoma
58
Myelodysplastic Syndromes
56
Lymphoma, Non-Hodgkin
54
Multiple Myeloma
52
Leukemia
43
Lymphoma, Mantle-Cell
40
Lymphoma
39
Lymphoma, Large B-Cell, Diffuse
37
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
37
Myeloproliferative Disorders
36
Lymphoma, Follicular
36
Lymphoma, B-Cell, Marginal Zone
33
Leukemia, Myelomonocytic, Chronic
28
Burkitt Lymphoma
28
Congenital Abnormalities
27
Anemia, Refractory, with Excess of Blasts
25
Waldenstrom Macroglobulinemia
24
Lymphoma, Large-Cell, Immunoblastic
24
Leukemia, Myeloid, Chronic-Phase
24
Hematologic Neoplasms
23
Primary Myelofibrosis
22
Leukemia, Myeloid, Accelerated Phase
20
Blast Crisis
19
Graft vs Host Disease
18
Neoplasms, Plasma Cell
17
Leukemia, Prolymphocytic
17
Leukemia, Myelomonocytic, Juvenile
17
Interventions
ponatinib
4
pembrolizumab
3
Rituximab
3
Gemcitabine
3
Cyclophosphamide
3
130-nm albumin-bound paclitaxel
3
pralsetinib
2
napabucasin
2
Vincristine
2
Prednisone
2
Irinotecan
2
Imatinib Mesylate
2
Etoposide
2
Doxorubicin
2
Carboplatin
2
Brentuximab Vedotin
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
ricolinostat
1
pomalidomide
1
pamiparib
1
nirogacestat
1
nilotinib
1
ibritumomab tiuxetan
1
denileukin diftitox
1
bosutinib
1
blinatumomab
1
Vorinostat
1
Temozolomide
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms by Histologic Type
×
Mycophenolic Acid
×
Clear all
No trials found.